-
SICEM 2025
SICEM 2025
- Program
- Abstracts
-
Participation
Participation
- Venue
-
News & Gallery
News & Gallery
LOG IN
SIGN UP
KESScientific program
Breakfast symposium
-
Breakfast symposium 1 [GSK & Lilly]
Day 2, Friday, May 2, 07:30-08:20 / Room 1 (B2)
Chairpersons : Tae Sun Park (Jeonbuk National University, Korea), Hong-Kyu Kim (University of Ulsan, Korea)
07:30-07:45
The importance of shingles prevention in patients with endocrine diseases
Mihye Seo (Soon Chun Hyang University, Korea)
07:45-08:00
Time to revolutionize T2D treatment with GIP/GLP-1 RA dual agonist
Young Sang Lyu (Chosun University, Korea)
-
Breakfast symposium 2. [Hanmi-Pharm & Bukwang-Pharm]
Day 2, Friday, May 2, 07:30-08:20 / Room 2 (B2)
Chairpersons : Sung-Hoon Kim (Mizmedi Hospital, Korea), Jae Hyuk Lee (Hanyang University, Korea)
07:30-07:45
It's time to break therapeutic inertia in dyslipidemia treatment
Shinae Kang (Yonsei University, Korea)
07:45-08:00
Treatment strategies for diabetic peripheral neuropathy based on its pathogenesis
Jung Hwan Park (Hanyang University, Korea)
-
Breakfast symposium 3. [HK inno.N & Bayer]
Day 3, Saturday, May 3, 07:30-08:20 / Room 1 (B2)
Chairpersons : Chang Beom Lee (Hanyang University, Korea), Sin Gon Kim (Korea University, Korea)
07:30-07:45
Cardiorenal benefits of Dapa.N for CKD patients (Dapagliflozin)
Seung Jin Han (Ajou University, Korea)
07:45-08:00
Real world evidence of finerenone in CKD with T2D treatment
Jun Sung Moon (Yeungnam University, Korea)
-
Breakfast symposium 4. [Boryung & Daiichi-Sankyo]
Day 3, Saturday, May 3, 07:30-08:20 / Room 2 (B2)
Chairpersons : Kyu Jeung Ahn (Kyunghee University, Korea), Dong Jin Chung (Chonnam National University, Korea)
07:30-07:45
TRUE BUDDY Combination therapy: benefits for diabetic complications and MASLD
Jun Hwa Hong (Eulji university, Korea)
07:45-08:00
Strategy for intensive BP management in patients with DM: focusing on Olmesartan family
Seeun Park (Sungkyunkwan University, Korea)
- Breakfast symposium 1 [GSK & Lilly] Day 2, Friday, May 2, 07:30-08:20 / Room 1 (B2)
Chairpersons : Tae Sun Park (Jeonbuk National University, Korea), Hong-Kyu Kim (University of Ulsan, Korea)
|
|
07:30-07:45 | The importance of shingles prevention in patients with endocrine diseases Mihye Seo (Soon Chun Hyang University, Korea) |
|
|
07:45-08:00 | Time to revolutionize T2D treatment with GIP/GLP-1 RA dual agonist Young Sang Lyu (Chosun University, Korea) |
- Breakfast symposium 2. [Hanmi-Pharm & Bukwang-Pharm] Day 2, Friday, May 2, 07:30-08:20 / Room 2 (B2)
Chairpersons : Sung-Hoon Kim (Mizmedi Hospital, Korea), Jae Hyuk Lee (Hanyang University, Korea)
|
|
07:30-07:45 | It's time to break therapeutic inertia in dyslipidemia treatment Shinae Kang (Yonsei University, Korea) |
|
|
07:45-08:00 | Treatment strategies for diabetic peripheral neuropathy based on its pathogenesis Jung Hwan Park (Hanyang University, Korea) |
- Breakfast symposium 3. [HK inno.N & Bayer] Day 3, Saturday, May 3, 07:30-08:20 / Room 1 (B2)
Chairpersons : Chang Beom Lee (Hanyang University, Korea), Sin Gon Kim (Korea University, Korea)
|
|
07:30-07:45 | Cardiorenal benefits of Dapa.N for CKD patients (Dapagliflozin) Seung Jin Han (Ajou University, Korea) |
|
|
07:45-08:00 | Real world evidence of finerenone in CKD with T2D treatment Jun Sung Moon (Yeungnam University, Korea) |
- Breakfast symposium 4. [Boryung & Daiichi-Sankyo] Day 3, Saturday, May 3, 07:30-08:20 / Room 2 (B2)
Chairpersons : Kyu Jeung Ahn (Kyunghee University, Korea), Dong Jin Chung (Chonnam National University, Korea)
|
|
07:30-07:45 | TRUE BUDDY Combination therapy: benefits for diabetic complications and MASLD Jun Hwa Hong (Eulji university, Korea) |
|
|
07:45-08:00 | Strategy for intensive BP management in patients with DM: focusing on Olmesartan family Seeun Park (Sungkyunkwan University, Korea) |